Literature DB >> 15362038

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction.

Elena F Verdú1, Premysl Bercík, Gabriela E Bergonzelli, Xian-Xi Huang, Patricia Blennerhasset, Florence Rochat, Muriel Fiaux, Robert Mansourian, Irène Corthésy-Theulaz, Stephen M Collins.   

Abstract

BACKGROUND & AIMS: The effects of probiotics on gut dysfunction in postinfective irritable bowel syndrome are unknown. We tested whether probiotics influence persistent muscle hypercontractility in mice after recovery from infection with Trichinella spiralis and analyzed the underlying mechanisms.
METHODS: Mice were gavaged with Lactobacillus paracasei, Lactobacillus johnsonii, Bifidobacterium longum, or Bifidobacterium lactis in spent culture medium from days 10 to 21 after infection. Additional mice received heat-inactivated Lactobacillus paracasei, Lactobacillus paracasei -free spent culture medium, or heat-inactivated Lactobacillus paracasei -free spent culture medium. Lactobacilli enumeration, immunohistochemistry, and cytokine detection (enzyme-linked immunosorbent assay) were performed. Mice were also treated with Lactobacillus paracasei or Lactobacillus paracasei -free spent culture medium from days 18 to 28 after infection. Contractility was measured on days 21 and 28 after infection.
RESULTS: Lactobacillus paracasei, but not Lactobacillus johnsonii, Bifidobacterium lactis, or Bifidobacterium longum, attenuated muscle hypercontractility. This was associated with a reduction in the Trichinella spiralis -associated T-helper 2 response and a reduction in transforming growth factor-beta1, cyclooxygenase-2, and prostaglandin E 2 levels in muscle. Attenuation of muscle hypercontractility by Lactobacillus paracasei -free spent culture medium was abolished after heat treatment. Improvement of muscle hypercontractility at day 28 after infection was also observed after the administration of Lactobacillus paracasei or Lactobacillus paracasei -free spent culture medium from day 18 after infection.
CONCLUSIONS: Probiotics show strain-dependent attenuation of muscle hypercontractility in an animal model of postinfective irritable bowel syndrome. This likely occurs via both a modulation of the immunologic response to infection and a direct effect of Lactobacillus paracasei or a heat-labile metabolite on postinfective muscle hypercontractility. Lactobacillus paracasei may be useful in the treatment of postinfective irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362038     DOI: 10.1053/j.gastro.2004.06.007

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

Review 1.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

2.  Effect of probiotics on gastrointestinal function: evidence from animal models.

Authors:  Elena F Verdú; Premysl Bercik; Stephen M Collins
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

3.  Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats.

Authors:  T Kamiya; L Wang; P Forsythe; G Goettsche; Y Mao; Y Wang; G Tougas; J Bienenstock
Journal:  Gut       Date:  2005-12-16       Impact factor: 23.059

Review 4.  Post-infectious irritable bowel syndrome.

Authors:  Marroon Thabane; John K Marshall
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

Review 5.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

6.  The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication.

Authors:  P Bercik; A J Park; D Sinclair; A Khoshdel; J Lu; X Huang; Y Deng; P A Blennerhassett; M Fahnestock; D Moine; B Berger; J D Huizinga; W Kunze; P G McLean; G E Bergonzelli; S M Collins; E F Verdu
Journal:  Neurogastroenterol Motil       Date:  2011-10-11       Impact factor: 3.598

7.  Gut bacteria in health and disease.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

8.  Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice.

Authors:  E F Verdú; P Bercik; M Verma-Gandhu; X-X Huang; P Blennerhassett; W Jackson; Y Mao; L Wang; F Rochat; S M Collins
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

Review 9.  Intestinal microbiota and its role in irritable bowel syndrome (IBS).

Authors:  Lena Ohman; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2013-05

Review 10.  The intestinal microbiome, probiotics and prebiotics in neurogastroenterology.

Authors:  Delphine M Saulnier; Yehuda Ringel; Melvin B Heyman; Jane A Foster; Premysl Bercik; Robert J Shulman; James Versalovic; Elena F Verdu; Ted G Dinan; Gail Hecht; Francisco Guarner
Journal:  Gut Microbes       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.